Your browser doesn't support javascript.
loading
Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event.
Navaie, Maryam; Celli, Bartolome R; Xu, Zhun; Cho-Reyes, Soojin; Dembek, Carole; Gilmer, Todd P.
Affiliation
  • Navaie M; Advance Health Solutions, New York, New York.
  • Celli BR; School of Professional Studies, Columbia University, New York, New York.
  • Xu Z; Harvard Medical School and Chronic Obstructive Pulmonary Disease Center, Brigham and Women's Hospital, Boston, Massachusetts.
  • Cho-Reyes S; Department of Family Medicine and Public Health, Division of Health Policy, University of California San Diego, La Jolla.
  • Dembek C; Advance Health Solutions, New York, New York.
  • Gilmer TP; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts.
Chronic Obstr Pulm Dis ; 6(4)2019 Oct 23.
Article in En | MEDLINE | ID: mdl-31483988
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Prognostic_studies Language: En Journal: Chronic Obstr Pulm Dis Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Prognostic_studies Language: En Journal: Chronic Obstr Pulm Dis Year: 2019 Document type: Article Country of publication: United States